معرفی
Sina Nikayin, MD, is an Assistant Professor Adjunct in Psychiatry at Yale School of Medicine and a psychiatrist at the Yale Interventional Psychiatry Service (IPS). He specializes in advanced modalities for treatment-resistant depression (TRD), including ketamine, esketamine, electroconvulsive therapy (ECT), and transcranial magnetic stimulation (TMS). His research focuses on the efficacy and safety of these interventions, particularly in bipolar and Parkinson's disease contexts.
Education: MD from Tehran University of Medical Sciences. He is affiliated with the Center for Brain & Mind Health and contributes to clinical trials like the Ketamine Parkinson’s Disease (PD) trial. His research interests include catatonia, delirium, and patient-reported outcomes. Recent work explores ketamine vs ECT efficacy, psychedelic therapy expectations, and genetic factors in severe depression.
Publications span 20+ peer-reviewed articles, emphasizing clinical trials and interventional psychiatry advancements. Collaborations include Gerard Sanacora and Samuel Wilkinson. No specific awards are listed, though his work reflects significant contributions to mental health innovation.